PIQUR is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs based on lipid kinase (PI3K) and mTOR inhibition. PIQUR's pipeline originates from one of the most promising research areas in oncology. While mTOR...Show all
Company (Alive / Active)
Phone: +41 61 633 29 29
Hochbergerstrasse 60C
Basel, CH-4057
Switzerland
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Name | Firm |
---|---|
Login to see details | Versant Ventures |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Novel manufacturing process for triazine, pyrimidine and pyridine derivatives | Jul 25, 2018 | Sep 08, 2020 | Patent |
Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | Nov 10, 2015 | May 05, 2020 | Patent |
Novel manufacturing process for triazine, pyrimidine and pyridine derivatives | Apr 20, 2015 | Oct 16, 2018 | Patent |
Conformationally restricted p13k and mtor inhibitors | Oct 03, 2014 | Jan 31, 2017 | Patent |
Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | Mar 13, 2020 | Application |